Skip Navigation

European Heart Journal 2002 23(5):355-370; doi:10.1053/euhj.2001.2706
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (75)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mannheimer, C.
Right arrow Articles by Thelle, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannheimer, C.
Right arrow Articles by Thelle, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina

C. Mannheimera,f1, P. Camicib, M.R. Chesterc, A. Collinsd, M. DeJongstee, T. Eliassona, F. Follathf, I. Hellemansg, J. Herlitzh, T. Lüscheri, M. Pasicj and D. Thellek

a Multidisciplinary Pain Center, Department of Medicine, SU/Östra, Göteborg, Sweden
b MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, London, U.K.
c National Refractory Angina Centre, Liverpool, U.K.
d Taunton and Somerset Hospital, Taunton, Somerset, U.K.
e Afdeling Cardiologie, Academisch Ziekenhuis Groningen, Groningen, The Netherlands
f Department für Innere Medizin, Universitätsspital, Zürich, Switzerland
g Amsterdam, The Netherlands
h Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden
i Department für Innere Medizin, Kardiologie, Universitätsspital, Zürich, Switzerland
j Deutsches Herzzentrum Berlin, Berlin, Germany
k Institute of Heart and Lung Diseases, Göteborg University, Göteborg, Sweden

revised March 27, 2001; accepted March 28, 2001

Key Words: Refractory angina pectoris.

f1 Correspondence: Dr Clas Mannheimer, Multidisciplinary Pain Center, Department of Medicine, SU/Östra, SE-416 85 Göteborg, Sweden.

References

  1. Eliasson T, Mannheimer C. Spinal cord stimulation in severe angina pectoris—presentation of current studies, indications and clinical experience. Pain. 1996;65:169–179[CrossRef][Web of Science][Medline]
  2. Eur Heart J. 1997;18:394–413[Free Full Text]
  3. Mulcahy D, Knight C, Stables R. Lasers, burns, cuts, tingles and pumps: a consideration of alternative treatments for intractable angina (editorial). Br Heart J. 1994;71:406–407[Free Full Text]
  4. Schoebel F, Frazier H, Jessurun G. Refractory angina pectoris in end-stage coronary artery disease: Evolving therapeutic concepts. Am Heart J. 1997;134:587–602[CrossRef][Web of Science][Medline]
  5. Chester MR. Chronic refractory angina: Time to sort out a neglected and growing problem. Br J Cardiol. 2000;7:108–111
  6. Circulation. 1999;99:2829–2848[Free Full Text]
  7. Yusuf S. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial. Am J Cardiol. 1999;84:20M–25M[Web of Science][Medline]
  8. Cosín J, Asín E, Marrugat J. Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol. 1999;4:323–330
  9. Brorsson, B, Persson, H, Landelius, P, Werkö, L, Smärtor i bröstet: Operation, ballongvidgning, medicinsk behandling
  10. Mannheimer C. Therapeutic challenges of refractory angina pectoris. 1998. p. 119
  11. Kannel W, Abbott R. Incidence and prognosis of unrecognised myocardial infarction: an update on the Framingham study. N Engl J Med. 1984;311:114–117
  12. Epstein S, Quyyumi A, Bonow R. Current concepts, myocardial ischemia: silent or symptomatic. N Engl J Med. 1988;318:1038–1043[Web of Science][Medline]
  13. Schang S, Pepine C. Transient asymptomatic ST segment depression during daily activity. Am J Cardiol. 1977;39:396–402[CrossRef][Web of Science][Medline]
  14. Deanfield J, Maseri A, Selwyn A. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet. 1983;2:753–758[Web of Science][Medline]
  15. Quyyumi A, Mockus L, Wright C, Fox K. Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease: investigation of the frequency of nocturnal ischaemia and coronary artery spasm. Br Heart J. 1985;53:186–193[Abstract/Free Full Text]
  16. Klein J, Chao S, Berman D, Rozanski A. Is ‘silent’ myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation. 1994;89:1958–1966[Abstract/Free Full Text]
  17. Langer A, Freeman M, Josse R, Steiner G, Armstrong P. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol. 1991;67:1073–1078[CrossRef][Web of Science][Medline]
  18. Shakespeare C, Katritsis D, Crowther A, Cooper I, Coltart J, Webb-Peploe M. Differences in autonomic function in patients with silent and symptomatic myocardial ischaemia. Br Heart J. 1994;71:22–29[Abstract/Free Full Text]
  19. Collins P, Fox K. Pathophysiology of angina. Lancet. 1990;335:94–96[CrossRef][Web of Science][Medline]
  20. Casey K. Match and mismatch: identifying the neuronal determinants of pain. Ann Int Med. 1996;124:995–998[Abstract/Free Full Text]
  21. Crea F, Pupita G, Galassi A. Role of adenosine in pathogenesis of angina pain. Circulation. 1990;81:164–172[Abstract/Free Full Text]
  22. Gaspardone A, Crea F, Tomai F. Substance P potentiates the algogenic effects of the intra-arterial infusion of adenosine. J Am Coll Cardiol. 1994;24:477–482[Abstract]
  23. Crea F, Gaspardone A. New look to an old symptom: angina pectoris. Circulation. 1997;96:3766–3773[Abstract/Free Full Text]
  24. White J. Anatomic pathways and physiologic mechanisms. Circulation. 1957;16:644–655[Web of Science][Medline]
  25. Malliani A, Pagani M, Lombardi F. Visceral versus somatic mechanisms. New York: Churchill Livingstone; 1989.
  26. Meller S, Gebhart G. Visceral pain: a review of experimental studies. Neuroscience. 1992;48:501–524[CrossRef][Web of Science][Medline]
  27. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–979[Free Full Text]
  28. Price D. Psychological mechanisms of pain and analgesia. Seattle: IASP Press; 1999.
  29. Rosen S, Paulesu E, Frith C, Frackowiak R, Jones T, Camici P. Central nervous pathways mediating angina pectoris. Lancet. 1994;344:147–150[CrossRef][Web of Science][Medline]
  30. Rosen S, Paulesu E, Nihoyannopoulos P. Silent ischaemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Int Med. 1996;124:939–949[Abstract/Free Full Text]
  31. Chester M. Draft guidelines for the management of refractory angina on behalf of the UK Refractory Angina Group. Eur Heart J. 1999;20:479[Web of Science][Medline]
  32. Eliasson T. Therapeutic options in severe angina pectoris and end-stage coronary artery disease. 1998. p. 119
  33. Grambow D, Topol E. Effect of maximal medical therapy on refractoriness of unstable angina pectoris. Am J Cardiol. 1992;70:577–581[CrossRef][Web of Science][Medline]
  34. Nägele H, Kalmar P, Labeck M. Transmyokardiale Laserrevaskularisation—Behandlungsoption bei der koronaren Herzerkrankung. Z Kardiol. 1997;86:171–178[CrossRef][Web of Science][Medline]
  35. Knight C, Fox K. Amlodipine vs diltiazem as antianginal treatment to atenolol. Am J Cardiol. 1998;81:133–136[CrossRef][Web of Science][Medline]
  36. Dunselman P, Liem A, Verdel G. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Eur Heart J. 1997;18:1755–1764[Abstract/Free Full Text]
  37. Emanuelsson H, Egstrup K, Nikus K. Antianginal efficacy of the combination of felodipine-metoprolol 10/100mg compared with each drug alone in patients with stable effort-induced angina pectoris: A multicenter parallel group study. Am Heart J. 1999;137:854–862[CrossRef][Web of Science][Medline]
  38. Frishman W, Glasser S, Stone P. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise peformance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol. 1999;83:507–514[CrossRef][Web of Science][Medline]
  39. Hollingshead LM, Faulds D, Fitton A. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris. Drugs. 1992;44:835–857[Web of Science][Medline]
  40. Narahara KA, Singh BN, Karliner JS, Corday SR, Hossack KF. Bepridil hydrochloride compared with placebo in patients with stable angina pectoris. Am J Cardiol. 1992;69:37D–42D[CrossRef][Medline]
  41. Zusman RM, Higgins J, Christensen D, Boucher CA. Bepridil improves left ventricular performance in patients with angina pectoris. J Cardiovasc Pharmacol. 1993;22:474–480[Web of Science][Medline]
  42. Ciopor M, Fischer A, Turina J, Hess O. Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence on angina pectoris in patients with coronary heart disease. Schweiz Rundsch Med Prax. 1997;86:1849–1853[Medline]
  43. Meyer B, Amann F. Additional antianginal efficacy of amiodarone in patients with limiting angina pectoris. Am Heart J. 1993;125:996–1001[CrossRef][Web of Science][Medline]
  44. Andrews T, Raby K, Barry J. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 1997;95:324–328[Abstract/Free Full Text]
  45. van Boven A, Jukema L, Zwinderman A. Reduction of transient myocardial ischemia in addition to the conventional treatment in patients with angina pectoris. Circulation. 1996;94:1503–1505[Abstract/Free Full Text]
  46. Pitt B, Waters D, Brown WV. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med. 1999;341:70–76[Abstract/Free Full Text]
  47. Anderson T, Meredith J, Yeung A, Frei B, Selwyn A, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent vasomotion. N Engl J Med. 1995;332:488–493[Abstract/Free Full Text]
  48. Egashira K, Hirooka Y, Kai H. Reduction in serum cholesterol with pravastatin improves endothelium dependent coronary vasomotion in patients with hyper-cholesterolemia. Circulation. 1994;89:2519–2524[Abstract/Free Full Text]
  49. Gotto A. Lipid lowering, regression and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention. Seventh council meeting. Circulation. 1995;92:646–656[Free Full Text]
  50. Leung W, Lau C, Wong C. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet. 1993;341:1496–1500[CrossRef][Web of Science][Medline]
  51. Treasure C, Klein J, Weintraub W. Beneficial effect of cholsterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481–487[Abstract/Free Full Text]
  52. Leschke M, Schoebel F, Mecklenbeck W. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A randomised dose-response trial. J Am Cardiol. 1996;27:575–584
  53. Opioid Sensitivity of Non-Cancer Pain. Seattle: IASP Press; 1999.
  54. Schenck-Gustafsson K, Swahn E. Guidelines for the European cardiologist concerning hormone replacement therapy in postmenopausal women. Eur Heart J Supplements. 2000;2:G15–G16
  55. WHO, The rehabilitation of patients with cardiovascular diseases
  56. Eur Heart J. 1998;19:1434–1503[Free Full Text]
  57. Eur Heart J. 1992;13:
  58. Smith S, Blair S, Crique M. American Heart Association Consensus statement: Prevention of heart attack and death in patients with coronary artery disease. Circulation. 1995;92:2–4
  59. Wenger, N, Froelicher, E, Smith, L, Clinical Practice Guideline: Cardiac Rehabilitation
  60. Amarose-Tupler B, Tapp J, Carida R. Stress management through relaxation and imagery in the treatment of angina pectoris. J Cardiopulm Rehabil. 1989;9:348–355
  61. Krumholz H, Cohen B, Tsevat J. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol. 1993;22:1697–1702[Abstract]
  62. Taylor C, Houston-Miller N, Killen J, DeBusk R. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med. 1990;113:118–123[Abstract/Free Full Text]
  63. Jorenby D, Leischow S, Nides M. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685–691[Abstract/Free Full Text]
  64. O'Connor G, Buring J, Yusuf S. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80:234–244[Abstract/Free Full Text]
  65. Niebauer J, Hambrecht R, Velich T. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Circulation. 1997;96:2534–2541[Abstract/Free Full Text]
  66. Linxue L, Nohara R, Makita S. Effect of long-term exercise training on regional myocardial perfusion changes in patients with coronary artery disease. Jpn Circ J. 1999;63:73–78[CrossRef][Medline]
  67. Ades P, Grunvald M, Weiss R, Hanson J. Usefulness of myocardial ischemia as predictor of training effect in cardiac rehabilitation after acute myocardial infarction or coronary artery bypass grafting. Am J Cardiol. 1989;63:1032–1036[CrossRef][Web of Science][Medline]
  68. Leaf D, Kleinman M, Hamilton M, Deitrick R. The exercise-induced oxidative stress paradox: the effects of physical exercise training. Med Sci Sports Exerc. 1999;31:634–638[Web of Science][Medline]
  69. Mittleman M, Maclure M, Tofler G. Triggering of acute myocardial infarction by heavy exertion: protection against triggering by regular exertion. N Engl J Med. 1993;329:1677–1683[Abstract/Free Full Text]
  70. De Lorgeril M, Salen P, Martin J, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779–785[Abstract/Free Full Text]
  71. Payne T, Johnson C, Penzien C. Chest pain self-management training for patients with coronary artery disease. J Psychosom Res. 1994;38:409–418[CrossRef][Web of Science][Medline]
  72. Lewin R. Improving quality of life in patients with angina. Heart. 1999;82:654–655[Free Full Text]
  73. Lewin R, Thompson D, Taylor R. Cardiac Rehabilitation. Eur Heart J. 2000;21:860–861[Free Full Text]
  74. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363–370[CrossRef][Web of Science][Medline]
  75. Mannheimer C, Carlsson C-A, Ericsson K, Vedin A, Wilhelmsson C. Transcutaneous electrical nerve stimulation in severe angina pectoris. Eur Heart J. 1982;3:297–302[Abstract/Free Full Text]
  76. Mannheimer C, Carlsson C-A, Emanuelsson H, Vedin A, Waagstein F, Wilhelmsson C. The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation. 1985;71:308–316[Abstract/Free Full Text]
  77. Mannheimer C, Carlsson C-A, Vedin A, Wilhelmsson C. Transcutaneous electrical nerve stimulation (TENS) in angina pectoris. Pain. 1986;26:291–300[CrossRef][Web of Science][Medline]
  78. Sanderson J, Tomlinson B, Lau M. The effect of transcutaneous electrical nerve stimulation (TENS) on autonomic cardiovascular reflexes. Clin Auton Res. 1995;5:81–84[CrossRef][Web of Science][Medline]
  79. Sanderson J. Electrical neurostimulators for pain relief in angina. Br Heart J. 1990;63:141–143[Free Full Text]
  80. Börjesson M, Eriksson P, Dellborg M, Eliasson T, Mannheimer C. Transcutaneous electrical nerve stimulation in unstable angina pectoris. Cor Art Dis. 1997;8:543–550
  81. Mannheimer C, Augustinsson L-E, Carlsson C-A, Manhem K, Wilhelmsson C. Epidural spinal electrical stimulation in severe angina pectoris. Br Heart J. 1988;59:56–61[Abstract/Free Full Text]
  82. Kujacic V, Eliasson T, Mannheimer C, Jablonskiene D, Augustinsson L-E, Emanuelsson H. Assessment of the influence of spinal cord stimulation (SCS) on left ventricular function in patients with severe angina pectoris: an echocardiographic study. Eur Heart J. 1993;14:1238–1244[Abstract/Free Full Text]
  83. Hautvast R, Brouwer J, DeJongste M, Lie K. Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chronic intractable angina pectoris—a prospective ambulatory electrocardiographic study. Clin Cardiol. 1998;98:33–38
  84. Sanderson J, Woo K, Chung H, Chan W, Tse L, White H. The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X. Cor Art Dis. 1996;7:547–552
  85. Eliasson T, Jern S, Augustinsson L-E, Mannheimer C. Safety aspects of spinal cord stimulation in severe angina pectoris. Cor Art Dis. 1994;5:845–850
  86. DeJongste M, Hautvast R, Hillege H. Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris: a prospective, randomized, clinical study. J Am Coll Cardiol. 1994;:1592–1597
  87. Andersen C, Hole P, Oxhøj H. Does pain relief with spinal cord stimulation conceal myocardial infarction? Br Heart J. 1994;71:419–421[Abstract/Free Full Text]
  88. DeJongste M, Haaksma J, Hautvast R. Effects of spinal cord stimulation on myocardial ischemia during daily life in patients with severe coronary artery disease. Br Heart J. 1994;71:413–418[Abstract/Free Full Text]
  89. Mannheimer C, Eliasson T, Andersson B. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ. 1993;307:477–480[Abstract/Free Full Text]
  90. De Landsherre C, Mannheimer C, Habets A. Effect of spinal cord stimulation on regional myocardial perfusion assessed by positron emission tomugraphy. Am J Cardiol. 1992;69:1143–1149[CrossRef][Web of Science][Medline]
  91. Hautvast R, DeJongste M, Blanksma P. Spinal cord stimulation causes redistribution in myocardial perfusion during dipramidole stresss testing in patients with refractory angina pectoris as assessed by 13 NH3-positron emission tomography. Am J Cardiol. 1996;77:462–467[CrossRef][Web of Science][Medline]
  92. Mobilia G, Zuin G, Zanco P. Effects of spinal cord stimulation on regional myocardial blood flow in patients with refractory angina. A positron emission tomography study. (In italian). G Ital Cardiol. 1998;28:1113–1119[Medline]
  93. Norrsell H, Eliasson T, Mannheimer C. Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover. Eur Heart J. 1997;18:1890–1896[Abstract/Free Full Text]
  94. Emanuelsson H, Mannheimer C, Waagstein F, Wilhelmsson C. Catecholamine metabolism during pacing-induced angina pectoris and the effect of transcutaneous electrical nerve stimulation. Am Heart J. 1987;114:1360–1366[CrossRef][Web of Science][Medline]
  95. Eliasson T, Mannheimer C, Waagstein F. Myocardial turnover of endogenous opioids and calcitonin gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology. 1998;89:170–177[CrossRef][Web of Science][Medline]
  96. Sanderson J, Ibrahim B, Waterhouse D, Palmer R. Spinal electrical stimulation for intractable angina—long-term clinical outcome and safety. Eur Heart J. 1994;15:810–814[Abstract/Free Full Text]
  97. Hautvast R, DeJongste M, Staal M, van Gilst W, Lie K. Spinal cord stimulation in chronic intractable angina pectoris. A randomized, controlled efficacy study. Am Heart J. 1998;136:1114–1120[Web of Science][Medline]
  98. Greco S, Auriti A, Fiume D. Spinal cord stimulation for the treatment of refractory angina pectoris: a two year follow-up. PACE. 1999;22:26–32
  99. TenVaarwerk I, Jessurun G, DeJongste M. Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. Heart. 1999;82:82–88[Abstract/Free Full Text]
  100. Mannheimer C, Eliasson T, Augustinsson L-E. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation. 1998;97:1157–1163[Abstract/Free Full Text]
  101. Ekre O, Norrsell H, Währborg P, Eliasson T, Mannheimer C. Spinal cord stimulation and coronary artery bypass grafting provide equal improvement in quality of life—data from the ESBY Study (Abstr). Circulation. 2000;Suppl (October 31):
  102. De Jongste M. Clinical trials with spinal cord and transcutaneous electrical nerve stimulation. Eur Heart J (Abstr Suppl). 2000;21:128
  103. Bagger J, Jensen B, Johannsen G. Long-term outcome of spinal cord electrical stimulation in patients with refractory chest pain. Clin Cardiol. 1998;21:286–288[Web of Science][Medline]
  104. Blomberg S, Curelaru I, Emanuelsson H, Herlitz J, Pontén J, Ricksten S-E. Thoracic epidural anesthesia in patients with unstable angina pectoris. Eur Heart J. 1989;10:437–444[Abstract/Free Full Text]
  105. Blomberg S, Emanuelsson H, Herlitz J, Pontén J, Ricksten S-E. Thoracic epidural anasthesia in patients with unstable angina pectoris. Anest Analg. 1989;69:558–562[Abstract/Free Full Text]
  106. Blomberg S, Ricksten S-E. Thoracic epidural anaesthesia decrease the coincidence of ventricular arrhythmia during acute myocardial ischemia in the anaesthetized rat. Acta Anaesthesiol Scand. 1988;32:173–178[Web of Science][Medline]
  107. Olausson K, Magnusdottir H, Lurje L, Wennerblom B, Emanuelsson H, Ricksten S. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Circulation. 1997;96:2178–2182[Abstract/Free Full Text]
  108. Kock M, Blomberg S, Emanuelsson H, Lomsky M, Strömblad S-O, Ricksten S-E. Thoracic epidural anesthesia improves global and regional left ventricular function during stress-induced myocardal ischemia in patients with coronary artery disease. Anesth Analg. 1990;71:625–630[Abstract/Free Full Text]
  109. Gramling-Babb P, Miller M, Reeves S, Roy R, Zile M. Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience. Am Heart J. 1997;133:648–655[CrossRef][Web of Science][Medline]
  110. Francois-Franck C. Signification physiologique de la résection du sympathique dans la maladie de Basendour, l'èpilepsie, l'idiotie et de glaucome. Bull Acad Med. 1899;41:565–594
  111. Jonnesco T. Angine de poitrine guérie par la résection du sympathique cervicothoracique. Bull Acad Med. 1920;84:93–102
  112. Lindgren I. Angina pectoris, a clinical study with special reference to neurosurgical treatment. Acta Med Scand. 1950;1:1–141
  113. Drott C, Göthberg G, Claes G. Endoscopic procedures of the upper-thoracic sympathetic chain. Arch Surg. 1993;128:237–241[Abstract/Free Full Text]
  114. Claes G, Göthberg C. Endoscopic transthoracic electrocautery of sympathetic chain for palmar and axillary hyperhidrosis. Br J Surg. 1991;78:760[Web of Science][Medline]
  115. Wetterwik C, Claes G, Drott C. Endoscopic transthoracic sympathicotomy for severe angina. Lancet. 1995;345:97–98[CrossRef][Web of Science][Medline]
  116. Claes G, Drott C, Wettervik C. Angina pectoris treated by thoracoscopic sympathectomy. Cardiovasc Surg. 1996;4:830–831[CrossRef][Medline]
  117. Tygesen H, Claes G, Drott C. Effect of endoscopic transthoracic sympathicotomy on heart rate variability in severe angina pectoris. Am J Cardiol. 1997;79:1447–1452[CrossRef][Web of Science][Medline]
  118. Wiener L, Cox W. Influence of stellate ganglion block on angina pectoris and the post-exercise electrocardiogram. Am J Med Sci. 1966;252:289–295[CrossRef][Web of Science][Medline]
  119. Hammond C, Leach A, Chester M. Temporary sympathectomy for refractory angina (Abstr). Br Med J. 1999;81:19
  120. Titley G, Collins P. Interrupting the sympathetic outflow in causalgia and reflex sympathetic blockage: clinics take precautions, but few follow guidelines. BMJ. 1998;317:753[Free Full Text]
  121. Prys-Roberts C, Brown R. International practice of anaesthesia. Oxford: Butterworth-Heinemann; 1996. p. 2/141/6–2/141/7
  122. Lee J. Lee's synopsis of anaesthesia. Oxford: Butterworth-Heinemann; 1993. p. 637–690
  123. Masuda A, Fujiki A. Sinus arrest after right stellate ganglion block. Anesth Analg. 1994;79:607[Free Full Text]
  124. Murphy. Chronic pain: Stellate ganglion blocks. Miller R. Anesthesia. New York, Edinburgh, London, Melbourne: Churchill Livingstone; 1990. p. 1936–1937
  125. Arnér, S, Stellate blockade
  126. Wedel, Brown. Nerve blocks: Stellate ganglion block. Miller R. Anesthesia. New York, Edinburgh, London, Melbourne: Churchill Livingstone; 1990. p. 1431
  127. Schott G. Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy. A futile procedure for many patients. BMJ. 1998;316:792–793[Free Full Text]
  128. Chester M, Hammond C, Leach A. Long-term benefits of stellate ganglion block in severe chronic refractory angina. Pain. 2000;87:103–105[CrossRef][Web of Science][Medline]
  129. Chester MR, Hammond CH, Leach A. Long-term benefits of stellate ganglion block in severe chronic refractory angina. Pain. 2000;87:103–105[CrossRef][Web of Science][Medline]
  130. Sen P, Udwadia T, Kinare S, Parulkar G. Transmyocardal acupuncture: a new approach to myocardial revascularization. J Thorac Cardiovasc Surg. 1965;50:181–189[Web of Science][Medline]
  131. Mirhoseini M, Cayton M. Revascularization of the heart by laser. J Microsurg. 1981;2:253–260[Medline]
  132. Krabatsch T, Tambeur L, Lieback E, Shaper F, Hetzer R. Transmyocardial laser revascularization in the treatment of end-stage coronary artery disease. Ann Thorac Cardiovasc Surg. 1998;4:64–71[Medline]
  133. Horvath K, Cohn L, Cooley D. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113:645–654[Abstract/Free Full Text]
  134. Nagele H, Stubbe H, Nienaber, Rodiger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. Eur Heart J. 1998;19:1523–1530
  135. Lange RA, Hillis LD. Transmyocardial laser revascularization. N Engl J Med. 1999;341:1075–1076[CrossRef][Web of Science][Medline]
  136. Gassler N, Wintzer H-O, Stubbe H-M, Wulbrand A, Helmchen U. Transmyocardial laser revascularization: histologic features in human nonresponder myocardium. Circulation. 1997;95:371–375[Abstract/Free Full Text]
  137. Leszek R, Rainer M, Adolfo B, Dirk G, Christian B. Transmyocardial laser revascularization: lack of channel patency in an experimental pig model. Circulation. 1996;94:I-476
  138. Aaberge L, Nordstrand K, Dragsund M. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170–1177[Abstract/Free Full Text]
  139. Allen KB, Dowling RD, Fudge TL. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029–1036[Abstract/Free Full Text]
  140. Burkhoff D, Schmidt S, Schulman S. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Lancet. 1999;354:885–890[CrossRef][Web of Science][Medline]
  141. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021–1028[Abstract/Free Full Text]
  142. March R. Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled study. Semin Thorac Cardiovasc Surg. 1999;11:12–18[Medline]
  143. Schofield PM, Sharples LD, Caine N. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519–524[CrossRef][Web of Science][Medline]
  144. Rimoldi O, Burns SM, Rosen SD. Measurement of Myocardial Blood Flow With Positron Emission Tomography Before and After Transmyocardial Laser Revascularization. Circulation. 1999;100:II-134–II-138
  145. Kwong KF, Schuessler RB, Kanellopoulos GK, Saffitz JE, Sundt TM III. Nontransmural laser treatment incompletely denervates canine myocardium. Circulation. 1998;98:II-67–II-71
  146. Oesterle SN, Reifart NJ, Meier B, Lauer B, Schuler GC. Initial results of laser-based percutaneous myocardial revascularization for angina pectoris. Am J Cardiol. 1998;82:659–662[CrossRef][Web of Science][Medline]
  147. Laham R, Simons M, Pearlman J, Yaron U, Baim D. Biosense catheter direct laser myocardial revascularisation improves 30 day angina class, regional wall motion and perfusion of the treated zone(s) using MRI (abstract). J Am Coll Cardiol. 1999;33:333A
  148. Shawl F, Domanski M, Saul U. Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization. Am J Cardiol. 1999;83:498[CrossRef][Web of Science][Medline]
  149. Lauer B, Junghans U, Stahl F. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol. 1999;34:1663[Abstract/Free Full Text]
  150. Carmeliet P. Basic concepts of (myocardial) angiogenesis: role of vascular endothelial growth factor and angiopoietin. Curr Intervent Cardiol Reports. 1999;1:322–335
  151. Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967[Abstract/Free Full Text]
  152. Isner J. Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am J Cardiol. 1998;82:63S–64S[CrossRef][Web of Science][Medline]
  153. Carmeliet P. Mechanisms of arteriogenesis and arteriogenesis. Mat Med. 2000;6:389–395
  154. Tio R, Tkebuchava T, Scheuermann T. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther. 1999;10:2953–2960[CrossRef][Web of Science][Medline]
  155. Losordo D, Vale P, Isner J. Gene therapy for myocardial angiogenesis. Am Heart J. 1999;138:132–141
  156. Vale P, Losordo D, Milliken C, Esakof D, Isner J. Percutaneous myocardial gene transfer of phVEGF-2. Circulation. 1999;100:2462–2463[Free Full Text]
  157. Arora R, Chou T, Jain D. The multicenter study of enhanced external counterpulsation (MUST—EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833[Abstract/Free Full Text]
  158. Urano H, Ikeda J, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93–99[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Ardell, R. Cardinal, M. Vermeulen, and J. A. Armour
Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R470 - R477.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. V. Arnold, J. A. Spertus, P. S. Ciechanowski, L. A. Soine, K. Jordan-Keith, J. H. Caldwell, and M. D. Sullivan
Psychosocial Modulators of Angina Response to Myocardial Ischemia
Circulation, July 14, 2009; 120(2): 126 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Cleveland Clinic Journal of MedicineHome page
M. J.L. DEJONGSTE, G. J. TERHORST, and R. D. FOREMAN
Basic research models for the study of underlying mechanisms of electrical neuromodulation and ischemic heart-brain interactions
Cleveland Clinic Journal of Medicine, April 1, 2009; 76(Suppl_2): S41 - S46.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Sajadieh
A new combination therapy in stable angina pectoris
Eur. Heart J., March 1, 2009; 30(5): 524 - 525.
[Full Text] [PDF]

Home page
 Eur J EchocardiogrHome page
M. Esmaeilzadeh, A. Khaledifar, M. Maleki, A. Sadeghpour, N. Samiei, H. Moladoust, F. Noohi, Z. O. Haghighi, and A. Mohebbi
Evaluation of left ventricular systolic and diastolic regional function after enhanced external counter pulsation therapy using strain rate imaging
Eur J Echocardiogr, January 1, 2009; 10(1): 120 - 126.
[Abstract] [Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza
CHAPTER 17 Chronic Ischaemic Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
T. Siminiak and J. Lipiecki
Trans-Coronary-Venous Interventions
Circ Cardiovasc Interv, October 1, 2008; 1(2): 134 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Baldazzi, E. Jorgensen, R. S. Ripa, and J. Kastrup
Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
Eur. Heart J., August 1, 2008; 29(15): 1819 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
P. Ferrero, D. Castagno, R. Massa, A. De Luca, M. Castellano, C. Chirio, and R. Grimaldi
Spinal cord stimulation affects T-wave alternans in patients with ischaemic cardiomyopathy: a pilot study
Europace, April 1, 2008; 10(4): 506 - 508.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
M. McGillion, H. Arthur, P. Andrell, and J. Watt-Watson
Self management training in refractory angina
BMJ, February 16, 2008; 336(7640): 338 - 339.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
H.-F. Tse, S. Thambar, Y.-L. Kwong, P. Rowlings, G. Bellamy, J. McCrohon, P. Thomas, B. Bastian, J. K.F. Chan, G. Lo, et al.
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)
Eur. Heart J., December 2, 2007; 28(24): 2998 - 3005.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M. R Chester, J. D Bridson, and G. A Lanza
Alternative treatments for angina
Heart, August 1, 2007; 93(8): 983 - 984.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
H.-F. Tse, C.-W. Siu, S.-G. Zhu, L. Songyan, Q.-Y. Zhang, W.-H. Lai, Y.-L. Kwong, J. Nicholls, and C.-P. Lau
Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium
Eur J Heart Fail, August 1, 2007; 9(8): 747 - 753.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
H.-F. Tse and C.-P. Lau
Therapeutic Angiogenesis With Bone Marrow--Derived Stem Cells
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 89 - 97.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
S. Banai, S. Ben Muvhar, K. H. Parikh, A. Medina, H. Sievert, A. Seth, J. Tsehori, Y. Paz, A. Sheinfeld, and G. Keren
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1783 - 1789.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S. Eddicks, K. Maier-Hauff, M. Schenk, A. Muller, G. Baumann, and H. Theres
Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study
Heart, May 1, 2007; 93(5): 585 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Southerland, D. M. Milhorn, R. D. Foreman, B. Linderoth, M. J. L. DeJongste, J. A. Armour, V. Subramanian, M. Singh, K. Singh, and J. L. Ardell
Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H311 - H317.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. Lapenna, D. Rapati, P. Cardano, M. De Bonis, F. Lullo, A. Zangrillo, and O. Alfieri
Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery
Ann. Thorac. Surg., November 1, 2006; 82(5): 1704 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
P. G. Steg and D. Tchetche
Pharmacologic management of stable angina: role of ivabradine
Eur. Heart J. Suppl., September 1, 2006; 8(suppl_D): D16 - D23.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
M. Stritesky, M. Dobias, R. Demes, M. Semrad, E. Poliachova, T. Cermak, J. Charvat, and I. Malek
Endoscopic thoracic sympathectomy - its effect in the treatment of refractory angina pectoris
Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 464 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. A. Cairns
Ranolazine: Augmenting the Antianginal Armamentarium
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 576 - 578.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D. McNab, S. N. Khan, L. D. Sharples, J. Y. Ryan, C. Freeman, N. Caine, S. Tait, I. Hardy, and P. M. Schofield
An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial
Eur. Heart J., May 1, 2006; 27(9): 1048 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. E. Nordrehaug and M. Salem
Treatment of chronic refractory angina pectoris--light at the end of the tunnel?
Eur. Heart J., May 1, 2006; 27(9): 1007 - 1009.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
P. Gabriel Steg and D. Himbert
Unmet medical needs and therapeutic opportunities in stable angina
Eur. Heart J. Suppl., September 1, 2005; 7(suppl_H): H7 - H15.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Abdi and Z. Yang
A Novel Technique for Experimental Stellate Ganglion Block in Rats
Anesth. Analg., August 1, 2005; 101(2): 561 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Palliat MedHome page
C. A Douglas, R. K. Moore, A. Leach, and M. R Chester
Modified-release opioids improve pain control and health-related quality of life in patients with complex cardiac chest pain
Palliative Medicine, December 1, 2004; 18(8): 740 - 741.
[PDF]

Home page
 Mayo Clin Proc.Home page
E. H. Yang, G. W. Barsness, B. J. Gersh, K. Chandrasekaran, and A. Lerman
Current and Future Treatment Strategies for Refractory Angina
Mayo Clin. Proc., October 1, 2004; 79(10): 1284 - 1292.
[Abstract] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
B. R. Chaitman
Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S47 - S64.
[Abstract] [PDF]

Home page
 HeartHome page
M. J L DeJongste, R. A Tio, and R. D Foreman
Chronic therapeutically refractory angina pectoris
Heart, February 1, 2004; 90(2): 225 - 230.
[Full Text] [PDF]

Home page
 HeartHome page
R M Sinvhal, R M Gowda, and I A Khan
Enhanced external counterpulsation for refractory angina pectoris
Heart, August 1, 2003; 89(8): 830 - 833.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M.-H. Huang, G. A. Ewy, M. Bassan, A. Collins, D. J. Pennell, J. R. Panting, P. Collins, and J. A. Panza
Cardiac Syndrome X
N. Engl. J. Med., October 24, 2002; 347(17): 1377 - 1379.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. J. L. DeJongste, R. W. M. Hautvast, and R. A. Tio
Therapeutic options for patients with chronic refractory angina pectoris
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1541 - 1541.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Meurin
Does 'more' mean maximal therapy
Eur. Heart J., September 2, 2002; 23(18): 1480 - 1480.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (75)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mannheimer, C.
Right arrow Articles by Thelle, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannheimer, C.
Right arrow Articles by Thelle, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?